TPTeresa Pérez

Teresa Pérez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Teresa Pérez has a total of 514 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating methods to quantify the effect of deprescribing a medication on patient clinical outcomes using a simulation study

    by Ryan Muddiman, Teresa Pérez Pérez, Florencia Inés Aiello Battan, Emma Wallace, Tom Fahey, Mary E. Walsh, Fiona Boland, Li Wei, Frank Moriarty

    Observational studies using electronic health records are being increasingly used to answer research questions of interest in deprescribing, where a medication is intentionally discontinued or the dose reduced. Target trial emulation (TTE) is particularly attractive as it is guided by sound theoretical principles based on causal inference. In the field of deprescribing, the evaluation of TTE within a simulation setting can provide evidence on optimal approaches for implementation and compare different estimation approaches which theory cannot easily inform. Deprescribing studies are susceptible to time-dependent confounding, competing risks due to early adverse events, time-dependent effects and other data complexities which may render estimates biased if such aspects are not properly addressed. In this work, a Monte-Carlo simulation study was conducted to estimate the performance (bias and coverage) of seven methods within several synthetic data generating mechanisms involving the above characteristics. The methods implemented were Cox regression, inverse probability of treatment weighted (IPTW) Cox regression, naive sequential Cox regression, IPTW weighted sequential Cox regression, extended Cox regression and the parametric g-formula. The IPTW Cox regression and IPTW sequential Cox regression were the only methods achieving nominal coverage and unbiasedness under the scenarios evaluated.

  • Open Access

    Outdoor Footwear Characteristics Among Older Adults with Concern About Falling: A Secondary Analysis of the FEARFALL_CARE Nurse-Led Cluster-Randomised Trial

    by Nuria Alcolea-Ruiz, Candelas López-López, Teresa Pérez-Pérez, Sonia Alcolea, Emma Camino-Ortega, Francisco Javier Pérez-Rivas

    Background/Objectives: This exploratory secondary analysis described outdoor footwear among older adults with concern about falling (CaF), examined baseline associations, evaluated a nurse-led intervention, and explored associations with CaF and falls. Methods: Data came from 163 community-dwelling adults aged ≥ 65 years in the FEARFALL_CARE cluster-randomised trial across ten primary care centres. Footwear was observed at baseline and six months using an unvalidated four-criterion composite. Mixed-effects models were complemented by inverse probability weighting (IPW) and cluster-level sensitivity analyses. Results: At baseline, 37/163 randomised participants (22.7%; composite available for 158) wore footwear meeting all criteria. Female sex and dwelling type were associated with baseline classification in an exploratory model. The ground-level house category contained only six participants. At six months, 18/59 intervention participants (30.5%) and 12/69 controls (17.4%) met all criteria. The adjusted intervention estimate was imprecise (aOR = 1.92; 95% CI: 0.78–4.69; p = 0.151), as were the IPW estimate (aOR = 2.18; 95% CI: 0.91–5.24; p = 0.081) and the adjusted cluster-level difference (9.3 percentage points; 95% CI: −9.6–28.2; p = 0.290). Baseline classification was associated with follow-up classification (aOR = 4.24; 95% CI: 1.65–10.92; p = 0.002). No statistically significant association was detected between footwear classification trajectory and six-month Short FES-I scores (p = 0.808) or experiencing at least one fall (p = 0.884). Conclusions: Failure to meet predefined footwear criteria was common. Sensitivity analyses did not establish an intervention effect, and imprecision precludes concluding absence of benefit or of associations with CaF and falls. The prevalence of potentially modifiable characteristics supports considering footwear assessment within multifactorial fall-risk evaluation.

  • Open Access

    Global prevalence and patterns of benzodiazepine use among adolescents and young adults: A systematic review and meta-analysis

    by María José Ortega-Susín, Teresa Pérez, Dolores Remedios Serrano, Elena González-Burgos

  • Open Access

    Nurse-led multicomponent educational intervention in primary care to reduce fear of falling in older adults: a cluster randomized trial

    by Nuria Alcolea-Ruiz, Francisco Javier Pérez-Rivas, Teresa Pérez-Pérez, Sonia Alcolea, Candelas López-López

    Background: Fear of falling (FOF) and falls are prevalent and interconnected. Studies suggest that intervention programs can reduce FOF and prevent falls. The primary objective was to assess the effectiveness of this nurse-led intervention in reducing FOF. Methods: This two-arm, parallel, multicenter, cluster-randomized clinical trial was conducted in ten primary care facilities in Madrid, Spain. Participants were ≥ 65 years old with FOF, independent or mildly dependent, ambulatory, and cognitively intact. Recruitment began on February 13, 2023, and the final follow-up was completed on May 30, 2024. Randomization assigned five facilities per group (1:1). The intervention was a nurse-led multicomponent group programme combining exercise, fall-prevention education, and cognitive-behavioral techniques (five weekly sessions plus a two-hour booster at six months), compared to usual care. The primary outcome was the Short Falls Efficacy Scale-International (FES-I) score, collected at baseline and at months one, six, and 12. Additional variables included sociodemographic, functional, clinical, and usual footwear data. Blinding was limited to recruitment; professionals were unaware of assignments, data were coded and analyzed by an independent third party, and the principal investigator, involved in fieldwork, was not blinded. Intervention effects were evaluated in intention-to-treat and per-protocol populations using fixed-effects ANOVA or logistic regression models as appropriate, with facility nested within group. Mixed-effects and cluster-level analyses were conducted as sensitivity analyses. Results: A total of 163 randomized participants from 10 primary care facilities were analyzed (mean age: 77.8 SD = 6.1 years; 127 [78%] women). In the intention-to-treat analysis, mean Short FES-I score was significantly lower in the intervention group compared to the control group at one month (2.599 points, 95% CI: 0.942, 4.256, p < 0.001), although differences at six and twelve months were not statistically significant. In the dichotomous analysis, the proportion of participants without FOF was consistently higher in the intervention group at 12 months (42.6% vs. 16.2%, OR = 0.23, 95% CI: 0.066–0.758, p = 0.013), corresponding to a 77% reduction. No major adverse events or side effects were reported. Conclusions and implications: This nurse-led intervention was effective in reducing FOF in the short term, and although benefits were observed at long-term follow-up, these did not reach statistical significance, and the magnitude of the observed effect was lower than initially anticipated. No significant reduction in fall incidence was observed, the program proved feasible and well-tolerated. Integrating fear of falling assessment and targeted interventions into routine primary care could enhance older adults’ functional independence. Trial registration: Registered at ClinicalTrials.gov NCT05889910. Record Verification on May 8, 2023. Funded by the Official College of Nursing of Madrid (Grant AYD263_2022).


  • Open Access

    A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety

    by Ryan Muddiman, Florencia Inés Aiello Battan, John Tazare, Anna Schultze, Fiona Boland, Teresa Perez, Li Wei, Mary E. Walsh, Frank Moriarty

    Purpose: Simulation studies are used in pharmacoepidemiology for evaluating statistical methods in a controlled setting, whereby a known data‐generating mechanism allows evaluation of the performance of different approaches and assumptions. This study aimed to review simulation studies performed in pharmacoepidemiology. Methods: We conducted a review of all papers published in the journal of Pharmacoepidemiology and Drug Safety (PDS) over the period 2017–2024. We extracted data on study characteristics and key simulation choices such as the type of data‐generating mechanism used, inferential methods tested and simulation size. Results: Among 42 simulation studies included, 34 (81%) were informing comparative effectiveness/safety studies. Twenty‐two studies (52%) used simulation in the context of a clinical condition, and 36 (86%) used Monte‐Carlo simulation. Inputs not derived from empirical data alone ( n = 22, 52%) or in combination with real‐world data sources ( n = 19, 45%) were most often used for data generation. The complexity of simulations was often relatively low: although 31 studies (74%) generated data based on other covariates, time‐dependent covariates ( n = 3) and effects ( n = 4) were rarely implemented. Bias was the most often used performance measure ( n = 26, 62%), although notably 18 studies (43%) did not report uncertainty in the method. Conclusion: Simulations contributed a relatively small number of articles (3.2% of 1320) to PDS over 2017–2024. Greater focus on evaluating methods and inferential approaches, using simulation studies that are appropriately complex given clinical realities, may be beneficial to the pharmacoepidemiology field.


  • Open Access

    Discriminative ability of the Behavioural Indicators of Pain Scale-Brain Injury (Escala de Conductas Indicadoras de Dolor-Daño Cerebral) according to level of sedation in critically ill patients with acquired brain injury and disorders of consciousness: A multicentre observational study

    by Candelas López-López, Gemma Robleda-Font, Ignacio Latorre-Marco, Montserrat Solís-Muñoz, María Carmen Sarabia-Cobo, Antonio Arranz-Esteban, Francisco Paredes-Garza, Aaron Castanera-Duro, Mónica Bragado-León, Emilia Romero De-San-Pío, et al.


  • Open Access

    Oxidative stress and mitochondrial dysfunction in neuronal cells induced by commercial CBD products

    by A. Sanz-Pérez, B.J. Anaya, A.I. Fraguas-Sánchez, D.R. Serrano, T. Pérez, M. Spineli, P. Basilicata, M. Pieri, E. González-Burgos


  • Long-term WBE monitoring of alcohol, nicotine, and caffeine in two Spanish cities: COVID-19 impacts and beyond

    by Natalia Melones-Peña, Teresa Pérez, María Carmen Pardo, Emma Gracia-Lor

    Wastewater-based epidemiology (WBE) is a valuable tool for assessing population-level consumption of addictive substances. This study presents long-term WBE monitoring (2021–2025) of alcohol, nicotine, and caffeine in Madrid and Guadalajara (Spain), including the first city-wide spatial analysis in Europe. A total of 192 composite 24-h untreated wastewater samples were collected from nine wastewater treatment plants: one in Guadalajara and eight in Madrid. Regression models were applied to assess spatial and temporal trends, as well as the impact of key events such as the COVID-19 restrictions, New Year celebrations, and weekends. Key findings show that between 2021 and 2024 alcohol and nicotine use showed a decreasing trend in both cities, while caffeine consumption remained stable with slight increases. In Madrid, average alcohol consumption declined from 27.7 to 16.3 mL/day/person and nicotine by approximately 800 mg/day/1000 person; in Guadalajara, alcohol decreased from 13.1 to 7.7 mL/day/person and nicotine 500 mg/day/1000 person. In December 2023, full city-level estimates from Madrid revealed alcohol consumption between 12.8–18.4 mL/day/person, nicotine 2180–3300 mg/day/1000 person, and caffeine 68.5–134.7 mg/day/person. Notably, alcohol and nicotine reached their highest levels among the New Year periods during the 2022–2023 celebration, the first unrestricted one after the pandemic; levels during this period dropped in the following years. These results highlight temporal and spatial patterns in the consumption of legal substances and suggest shifts in public behavior after COVID-19 and the utility of WBE as a long-term monitoring tool for public health surveillance and planning. Graphical Abstract

  • Open Access

    Reliability and Validation Study of the Spanish Translation of the Nociception Coma Scale-Revised—Adapted for Intubated Patients (NCS-R-I)

    by Candelas López-López, Gemma Robleda-Font, María del Mar Sánchez-Sánchez, Carmen María Sarabia-Cobo, Ignacio Latorre-Marco, Montserrat Solís-Muñoz, Teresa Pérez-Pérez, Cristina Martín-Arriscado Arroba, Caroline Schnakers, Juan Roldan-Merino

    Background/Objectives: Pain assessment scales provide a clear clinical benefit in patients who are unable to self-report. The Nociception Coma Scale-Revised—adapted for Intubated patients (NCS-R-I) was developed to assess pain in patients with acquired brain injury who are unable to self-report. However, this instrument has not yet been translated and validated for use in Spain. The objective was to translate the Nociception Coma Scale-Revised—adapted for Intubated patients (NCS-R-I) into Spanish and to assess the reliability and validity of the Spanish version in patients with brain injury. Methods: This study was carried out in two phases. First, the scale was translated into Spanish. Next, a psychometric analysis was performed to determine the reliability and validity of the Spanish version of the NCS-R-I in 207 critically ill patients with acquired brain injury and disorders of consciousness. Two blinded observers administered the scale at three time points: 5 min before, during, and 15 min after a series of nociceptive and non-nociceptive procedures. Results: The internal consistency of the NCS-R-I was acceptable (ordinal alpha = 0.60–0.90). Interobserver agreement was good (kappa = 0.80; intraclass correlation coefficient = 0.90). In terms of discriminant validity, the AUC was 0.952 (95% CI: 0.931–0.973). NCS-R-I scores increased significantly during performance of nociceptive procedures compared to scores obtained before and after these procedures, confirming the scale’s sensitivity to change. Similarly, during the performance of nociceptive procedures, scores on the NCS-R-I were significantly higher (p < 0.001) than those observed during non-nociceptive procedures. Conclusions: The results of this study demonstrate that the NCS-R-I is a valid, reliable tool for the assessment of pain in patients with acquired brain injury who are unable to self-report.